{"id":8052,"date":"2025-07-23T10:26:44","date_gmt":"2025-07-23T07:26:44","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8052"},"modified":"2025-07-23T10:26:44","modified_gmt":"2025-07-23T07:26:44","slug":"scientific-summary-new-york-valves-2025-the-structural-heart-summit-late-breaking-clinical-trials-june-25-27-2025-latest-update-coverage-july-22-2025-medical-news-media","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/scientific-summary-new-york-valves-2025-the-structural-heart-summit-late-breaking-clinical-trials-june-25-27-2025-latest-update-coverage-july-22-2025-medical-news-media\/","title":{"rendered":"Scientific Summary: New York Valves 2025: The Structural Heart Summit \u2013 Late-Breaking Clinical Trials (June 25\u201327, 2025) Latest Update coverage: July 22, 2025 | Medical News Media"},"content":{"rendered":"

Scientific Summary:<\/span><\/p>\n

New York Valves 2025:<\/span>
\nThe Structural Heart Summit \u2013 Late-Breaking Clinical Trials (June 25\u201327, 2025)<\/span>
\nLatest Update coverage: July 22, 2025 | Medical News Media<\/span><\/p>\n

Overview:<\/span>
\n\u2022 New York Valves 2025 (June 25\u201327, NYC) was organized by the Cardiovascular Research Foundation (CRF), replacing the former TCT-Valves conference.It is a new international heart meeting focused on valve diseases and minimally invasive treatments.<\/span><\/p>\n

\u2022 The agenda included live cases, clinical science sessions, and 150+ abstracts. Each day focused on a specific heart valve:<\/span>
\n\u2022 Day 1: Aortic valve<\/span>
\n\u2022 Day 2: Tricuspid valve<\/span>
\n\u2022 Day 3: Mitral valve<\/span><\/p>\n

Day 1 \u2013 Aortic Valve Trials (June 25):<\/span>
\n1. EARLY TAVR Trial: Early treatment of severe aortic valve narrowing may be better than waiting.<\/span>
\n2. DETECT AS Trial: Using digital alerts helped reduce treatment delays for women.<\/span>
\n3. Redo TAVR Study: Analyzed outcomes of doing TAVR again or removing old valves.<\/span>
\n4. New Valve Design: Early results from a self-expanding valve used in the U.S. were promising.<\/span><\/p>\n

Day 2 \u2013 Tricuspid Valve Trials (June 26):<\/span>
\n1. TRILUMINATE Study: Showed how tricuspid disease worsens without treatment.<\/span>
\n2. TRISCEND II: One-year follow-up showed improved heart valve function after valve replacement.<\/span>
\n3. Tri-QOL Study: Defined what counts as a good result after tricuspid procedures.<\/span>
\n4. TRISPA Registries: Found that other valve problems affect outcomes after tricuspid repair.<\/span><\/p>\n

Day 3 \u2013 Mitral Valve Trials (June 27):<\/span>
\n1. Intrepid TMVR: Two-year results showed success with a new mitral valve placed through a leg vein.<\/span>
\n2. PASCAL System Study: Patients had better quality of life after using the PASCAL mitral system.<\/span>
\n3. Global Disease Report: Showed how common mitral valve disease is worldwide.<\/span>
\n4. Polymeric Valve Study: A new plastic-based mitral valve worked well after 1 year.<\/span><\/p>\n

Extra Highlight:<\/span>
\n\u2022 A special Left Atrial Appendage Closure (LAAC) session was held on June 26.<\/span><\/p>\n

This update showing how valve disease treatment is evolving quickly, with a focus on minimally invasive solutions and better outcomes for patients.<\/span><\/p>\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/40635862\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Scientific Summary: New York Valves 2025: The Structural Heart Summit \u2013 Late-Breaking Clinical Trials (June 25\u201327, 2025) Latest Update coverage: July 22, 2025 | Medical News Media Overview: \u2022 New York Valves 2025 (June 25\u201327, NYC) was organized by the Cardiovascular Research Foundation (CRF), replacing the former TCT-Valves conference.It is a new international heart meeting […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8052","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8052"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8052\/revisions"}],"predecessor-version":[{"id":8053,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8052\/revisions\/8053"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}